clinic
demograph
data
report
technic
appendix
tabl
fecal
sampl
asymptomat
infect
domest
cat
solicit
shelter
veterinarian
throughout
unit
state
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
fcov
primer
detect
circul
strain
use
screen
fecal
sampl
rna
extract
black
laboratoryadapt
strain
use
posit
control
analyz
fipvposit
tissu
sampl
veterinari
patholog
archiv
cornel
univers
ithacan
ny
usa
cat
fip
diagnosi
fip
base
standard
method
immunohistochem
evalu
boardcertifi
pathologist
sampl
retriev
formalinfix
paraffinembed
tissu
block
section
stain
use
fipv
antibodi
custom
monoclon
sacramento
ca
usa
posit
stain
region
thinli
section
rna
extract
use
recoveral
ambion
foster
citi
ca
usa
fecal
sampl
collect
fcovposit
housem
cat
process
previous
describ
section
refer
veterinarian
made
diagnosi
fip
cat
owner
elect
euthan
anim
fresh
tissu
harvest
rna
extract
use
magmax
express
life
technolog
grand
island
ny
usa
sampl
revers
transcript
pcr
rtpcr
perform
onestep
rtpcr
qiagen
use
genespecif
primer
encompass
pcr
primer
sequenc
found
technic
appendix
tabl
pcr
condit
min
min
cycl
min
min
min
min
pcr
product
purifi
use
qiaquick
gel
extract
kit
qiagen
sanger
sequenc
perform
life
scienc
core
laboratori
cornel
univers
nucleotid
archiv
access
number
shown
technic
appendix
tabl
dna
sequenc
translat
protein
sequenc
align
perform
use
geneiou
biomatt
ltd
auckland
new
zealand
sequenc
logo
gener
use
weblogo
http
weblogothreeplusonecom
statist
analysi
perform
use
fischer
exact
test
test
number
fipvinfect
fecvinfect
cat
count
categori
fipv
fecv
infect
cat
harbor
virus
without
mutat
site
count
fluorogen
peptid
design
synthes
rs
synthesi
louisvil
ks
usa
technic
appendix
tabl
purifi
recombin
human
furin
purchas
neb
ipswich
usa
reaction
unit
enzym
use
final
volum
use
reaction
buffer
nmoll
hepe
triton
mmoll
mmoll
ph
peptid
dilut
reaction
perform
triplic
fluoresc
measur
spectramax
fluoromet
molecular
devic
sunnyval
ca
usa
enabl
vmax
determin
result
peptid
express
percent
cleavag
furin
compar
canon
sequenc
perform
compar
analysi
cleavag
site
fecv
fipv
identifi
case
fip
confirm
postmortem
use
immunohistochemistri
standard
fip
diagnosi
archiv
immunohistochemistryposit
formalinfix
tissu
use
sourc
fipv
rna
ensur
good
qualiti
sequenc
inform
archiv
materi
rtpcr
amplicon
size
limit
includ
site
region
amplifi
fecal
materi
coronavirusposit
healthi
cat
sequenc
site
sequenc
fecv
fecal
sampl
reveal
extrem
wellconserv
motif
amino
acid
level
figur
panel
particular
arginin
r
residu
found
exclus
critic
posit
furin
recognit
cleavag
sequenc
analyz
figur
panel
b
posit
extrem
well
conserv
serin
found
case
posit
also
well
conserv
evidenc
clear
major
basic
residu
found
arginin
lysin
k
figur
panel
b
limit
variabl
found
serin
alanin
overal
fecv
sequenc
analyz
contain
furin
cleavag
site
core
motif
rrsarr
analysi
cleavag
site
fipv
sequenc
show
much
variabl
within
narrow
furin
cleavag
recognit
motif
residu
extend
figur
strike
observ
critic
posit
among
consist
mutat
figur
lesser
degre
variabl
extend
posit
cleavag
motif
notabl
posit
figur
examin
result
entir
portion
spike
sequenc
studi
indic
conserv
rrsarr
motif
fecv
present
within
region
spike
gene
show
high
degre
variabl
contrast
neighbor
region
highli
conserv
technic
appendix
figur
test
whether
identifi
fipv
mutat
effect
cleavabl
furin
perform
vitro
proteolyt
assay
use
human
furin
experi
human
felin
furin
similar
ident
expect
cleav
equival
manner
howev
felin
furin
directli
studi
degre
reagent
readili
avail
felin
human
cell
line
show
ident
rate
cleavag
known
furin
target
protein
contain
activ
furin
cleavag
site
technic
appendix
figur
use
fluorogen
peptid
contain
canon
motif
rrsrr
substitut
posit
figur
panel
canon
peptid
effici
cleav
furin
figur
averag
vmax
rel
fluoresc
unit
rfu
per
minut
within
core
peptid
canon
background
serin
residu
chang
leucin
l
furin
cleavag
sever
diminish
canon
cleavag
rate
result
show
key
role
conserv
serin
modif
arginin
canon
peptid
regardless
residu
test
exampl
glycin
g
methionin
threonin
abrog
cleavag
furin
figur
modif
arginin
residu
canon
peptid
variabl
effect
arginin
chang
histidin
h
complet
inhibit
canon
cleavag
chang
leucin
serin
cleavag
effici
reduc
respect
modifi
prolin
p
cleavag
effici
slightli
increas
canon
peptid
figur
sa
substitut
minim
enhanc
cleavag
figur
arginin
anoth
residu
posit
essenti
furin
cleavag
canon
peptid
rk
substitut
slight
decreas
cleavag
effici
canon
rate
contrast
arginin
substitut
glycin
furin
cleavag
complet
abrog
figur
posit
upstream
rk
tf
modif
moder
enhanc
effect
furin
cleavag
canon
rate
respect
hq
peptid
show
substanti
increas
cleavabl
compar
canon
hq
rk
peptid
show
effect
modif
addit
compar
canon
peptid
figur
confirm
find
analyz
site
viral
sampl
taken
cat
live
household
tabl
initi
sampl
cat
asymptomat
fip
shed
fcov
fece
sampl
cat
site
core
sequenc
rrsrr
consist
fecv
consensu
upon
second
sampl
fip
diagnos
cat
cat
remain
asymptomat
continu
shed
viru
fece
notabl
sequenc
analyz
second
sampl
cat
fip
chang
fecv
consensu
sequenc
rl
mutat
exhibit
chang
residu
sa
viru
present
cat
retain
conserv
furin
cleavag
motif
tabl
data
provid
direct
evid
mutat
spike
link
develop
fip
cat
studi
fip
taken
altern
approach
complement
earlier
studi
base
analyt
outcom
put
fipcaus
mutat
infer
function
consequ
focus
sequenc
specif
function
highli
relev
cleavag
site
within
protein
document
mutat
asymptomat
highli
symptomat
cat
correl
strongli
fip
also
document
function
cleavag
site
mutat
aros
asymptomat
cat
subsequ
develop
fip
sequenc
data
show
serotyp
fecv
fece
asymptomat
cat
contain
highli
conserv
furin
cleavag
motif
site
follow
narrow
rang
residu
r
kg
r
r
r
addit
consensu
rxkrr
motif
addit
flank
residu
also
consequenti
furinmedi
cleavag
particular
serin
residu
critic
posit
notabl
fecv
examin
contain
residu
fact
site
extrem
well
conserv
indic
function
essenti
fecv
replic
enter
epithelium
contrast
situat
asymptomat
cat
infect
fecv
found
sequenc
fcov
sampl
tissu
confirm
fipposit
cat
consist
mutat
site
critic
posit
furin
cleavag
found
fipv
mutat
arginin
residu
replac
aliphat
methionin
glycin
polar
uncharg
threonin
residu
overal
distinguish
featur
fipv
absenc
arginin
rather
presenc
particular
residu
corrobor
peptid
cleavag
data
demonstr
furin
cleavag
fulli
abrog
substitut
test
next
common
posit
mutat
fipv
fipv
analyz
bore
mutat
posit
mutat
residu
found
aliphat
p
l
sequenc
substitut
polar
basic
h
polar
uncharg
residu
apart
rp
substitut
peptid
cleavag
data
indic
substitut
inhibit
effect
furin
cleavag
note
murin
hepat
viru
mhv
betacoronaviru
also
harbor
cleavag
site
spike
protein
preced
inhibitori
effect
introduct
histidin
posit
cleavag
site
two
wellstudi
strain
mhv
strain
neurovirul
mhv
strain
jhm
mhvjhm
notabl
differ
site
rrshr
sequenc
less
effici
cleav
mhvjhm
rrassr
sequenc
gener
consid
critic
furin
cleavag
found
limit
variat
residu
posit
fipv
test
found
mutat
polar
basic
residu
k
polar
uncharg
residu
virus
peptid
data
indic
although
introduct
serin
complet
abrog
cleavag
substitut
minim
effect
fipv
posit
show
small
variat
compar
fecv
introduct
polar
uncharg
residu
sampl
posit
chang
slightli
higher
frequenc
lysin
residu
sampl
cat
fipv
peptid
cleavag
data
indic
common
sa
substitut
found
fecv
fipv
posit
slightli
increas
effect
proteolysi
furin
furthermor
substitut
enhanc
effect
peptid
cleavag
assay
conserv
polar
uncharg
residu
retain
major
fipv
sampl
howev
introduct
aliphat
amino
acid
l
found
notabl
furin
cleavag
suggest
incompat
hydrophob
aliphat
side
chain
strong
prefer
serin
posit
sampl
contain
l
basic
residu
within
site
remain
ident
one
found
fecv
sequenc
suggest
disrupt
furin
cleavag
mediat
mutat
rather
typic
andor
mutat
hypothesi
support
peptid
cleavag
assay
peptid
unabl
cleav
furin
overal
term
fipposit
anim
found
cat
harbor
virus
mutat
furin
motif
rrsarr
found
fecv
asymptomat
cat
fipposit
cat
sequenc
viral
rna
collect
differ
tissu
technic
appendix
tabl
data
provid
strong
support
intern
mutat
hypothesi
mutat
uniqu
individu
cat
note
tissu
anim
carri
mutat
instanc
mix
popul
virus
exist
within
anim
major
virus
sequenc
mutat
although
mutat
howev
appar
except
cat
harbor
virus
clearli
defin
mutat
furin
cleavag
site
sampl
cat
sampl
cat
consid
presenc
furin
cleavag
sampl
cat
consist
hypothesi
switch
activ
proteas
viru
typic
natur
occur
furin
cleavag
site
sampl
cat
harbor
viru
atyp
lysin
residu
unusu
fecv
lysin
residu
appear
compat
furin
cleavag
remain
determin
noteworthi
lysin
residu
versu
arginin
residu
context
proteas
switch
fipv
whether
mutat
correl
fipv
case
cat
part
studi
analyz
field
sampl
cat
harbor
fcov
differ
time
cat
viru
underw
transit
fecv
fipv
function
relev
mutat
motif
rl
cat
live
hous
cat
remain
asymptomat
cat
harbor
mutat
viru
mutat
function
irrelev
posit
sa
identif
cat
fecv
fip
subsequ
develop
challeng
present
singl
exampl
consid
data
strong
evid
mutat
site
link
chang
pathogen
properti
viru
like
essenti
acquisit
macrophag
tropism
seen
fip
cleavag
site
surround
residu
serotyp
fipv
sequenc
found
systemat
modifi
mutat
chang
et
al
recent
publish
extens
compar
analysi
fip
mutat
nucleotid
level
perform
wholegenom
sequenc
fecv
fipv
author
found
site
within
nucleotid
posit
outsid
frequent
mutat
fipv
undertaken
analysi
site
sequenc
chang
et
al
find
hypothesi
mutat
within
furin
motif
correl
fip
sampl
differ
methodolog
may
explain
lack
agreement
first
employ
immunohistochemistri
confirm
diagnosi
fip
chang
et
al
report
use
postmortem
examin
second
fip
sampl
studi
origin
tissu
chang
et
al
includ
tissu
ascit
fluid
final
report
multipl
sequenc
fipaffect
cat
chang
et
al
report
singl
sequenc
sequenc
data
sampl
provid
evid
fecv
fipv
popul
identifi
within
affect
anim
sequenc
inform
singl
sampl
may
adequ
detect
mutat
viru
mutat
neg
affect
furin
process
enhanc
given
major
fipv
protein
still
harbor
basic
residu
boundari
could
reason
mutat
site
becom
open
cleav
rang
proteas
switch
proteolyt
requir
propos
may
offer
explan
crucial
tropism
transit
fip
possibl
consequ
mutat
cleavabl
monocyticmacrophagespecif
proteas
could
proprotein
convertas
cathepsin
macrophagespecif
proteas
particular
cathepsin
b
matrix
metalloproteas
furinrel
like
express
surfac
macrophag
recogn
hallmark
residu
remain
acquir
fipv
cleavag
site
matrix
metalloproteas
particular
interest
demonstr
upregul
activ
monocyt
macrophag
fip
shift
entri
pathway
enabl
viru
entri
cell
surfac
instead
endosom
may
simultan
explain
abil
fipv
infect
macrophag
macrophag
resist
fecv
also
possibl
mutat
region
affect
heparin
sulfat
bind
site
region
howev
heparin
sulfat
bind
cell
cultur
adapt
viru
relev
clinic
situat
would
appear
unlik
contrast
view
intern
mutat
hypothesi
explain
genesi
fip
outbreak
circul
fcov
fecv
specif
fip
complex
diseas
process
fip
other
consid
like
may
circul
fecv
closer
make
critic
mutat
necessari
fip
possibl
explain
paradox
fip
outbreak
base
data
present
conclud
mutat
locu
modul
furin
recognit
site
normal
present
gene
fecv
critic
contribut
factor
develop
fip
studi
could
serv
analyz
mutat
fit
mutat
posit
account
fip
develop
